Sarepta Therapeutics (SRPT) Said to Price $300M at $59.75 - Feurstein

September 22, 2016 5:38 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Sarepta Therapeutics (NASDAQ: SRPT) offering 4-5x oversubscribed, offering $300 million at $59.75, Adam Feurstein tweets citing a source.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Equity Offerings, FDA, Momentum Movers, Trader Talk

Related Entities

Adam Feuerstein

Add Your Comment